Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $3.71 to $4.28
• 50-Day Range: $3.80 to $8.65
• 52-Week Range: $3.71 to $8.79
• Volume: 309,780 shs
• Average Volume: 182,935 shs
• Market Capitalization: $136.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR stock has decreased by 31.9% and is now trading at $3.80.
View the best growth stocks for 2025 here.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an IPO on Friday, December 13th 2024. The company issued 14,800,000 shares at $6.00 per share.

Who are Anteris Technologies Global's major shareholders?

Top institutional shareholders of Anteris Technologies Global include Nantahala Capital Management LLC (4.64%), Regal Partners Ltd (3.60%), ADAR1 Capital Management LLC (2.93%) and Ensign Peak Advisors Inc (2.89%).

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 3/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.50
• High Stock Price Target: $22.00
• Low Stock Price Target: $9.00
• Potential Upside/Downside: +334.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $2.71 million
• Price / Sales: 50.49
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 36,024,000
• Free Float: N/A
• Market Cap: $136.89 million
• Optionable: N/A
• Beta: N/A